18
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Induction of “In Vitro” Apoptosis by Fludarabine in Freshly Isolated B-Chronic Lymphocytic Leukemia Cells

, , , , , , , & show all
Pages 95-97 | Received 05 Jun 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Stuart M. Lichtman, Erlinda Etcubanas, Daniel R. Budman, Peter Eisenberg, George Zervos, Paul D'Amico, Vivian O'Mara, Kimberly Musgrave, Peter Cascella, Armen Melikian, Peter H. Hinderling, Jorge M. Ferrer & Gary J. Williams. (2002) The Pharmacokinetics and Pharmacodynamics of Fludarabine Phosphate in Patients with Renal Impairment: A Prospective Dose Adjustment Study. Cancer Investigation 20:7-8, pages 904-913.
Read now
Annalisa Pellacani, Patrizia Tosi, Pier Luigizinzani, Emanuela Ottaviani, Patrizia Albertini, Massimo Magagnoli & Sante Tura. (1999) Cytotoxic Combination of Loxoribine with Fludarabine and Mafosfamide on Freshly Isolated B-Chronic Lymphocytic Leukemia Cells. Leukemia & Lymphoma 33:1-2, pages 147-153.
Read now
Gianluca Gaidano, Cristina Pastore, Daniela Capello, Vania Cilli & Giuseppe Saglio. (1997) Molecular Pathways in Low Grade B-Cell Lymphoma. Leukemia & Lymphoma 26:sup1, pages 107-113.
Read now
Patrizia Tosi, Pier Luigi Zinzani, Annalisa Pellacani, Emanuela Ottaviani, Massimo Magagnoli & Sante Tura. (1997) Loxoribine Affects Fludarabine Activity on Freshly Isolated B-chronic Lymphocytic Leukemia Cells. Leukemia & Lymphoma 26:3-4, pages 343-348.
Read now
Asher Begleiter, Michael Mowat, Lyonel G. Israels & James B. Johnston. (1996) Chlorambucil in Chronic Lymphocytic Leukemia: Mechanism of Action. Leukemia & Lymphoma 23:3-4, pages 187-201.
Read now

Articles from other publishers (10)

L Polito, A Bolognesi, P L Tazzari, V Farini, C Lubelli, P L Zinzani, F Ricci & F Stirpe. (2004) The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. Leukemia 18:7, pages 1215-1222.
Crossref
Marcela Gonz?lez-Cid, Ariela F Fundia, Maria Teresa Cuello & Irene Larripa. (2002) Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes. Toxicology 171:2-3, pages 215-222.
Crossref
Radovan VrhovacAlain DelmerRuoping TangJean-Pierre MarieRobert ZittounFlorence Ajchenbaum-Cymbalista. (1998) Prognostic Significance of the Cell Cycle Inhibitor p27Kip1 in Chronic B-Cell Lymphocytic Leukemia. Blood 91:12, pages 4694-4700.
Crossref
Beatriz BellosilloMireia DalmauDolors ColomerJoan Gil. (1997) Involvement of CED-3/ICE Proteases in the Apoptosis of B-Chronic Lymphocytic Leukemia Cells. Blood 89:9, pages 3378-3384.
Crossref
Peter W. MesnerJr.Jr., I. Imawati Budihardjo & Scott H. Kaufmann. 1997. Apoptosls - Pharmacological Implications and Therapeutic Opportunities. Apoptosls - Pharmacological Implications and Therapeutic Opportunities 461 499 .
Jill M. Kolesar, Ashley K. Morris & John G. Kuhn. (2016) Review : Purine nucleoside analogues: Fludarabine, pentostatin, and cladribine. Journal of Oncology Pharmacy Practice 2:3, pages 160-181.
Crossref
Panos Fidias, Bruce A. Chabner & Michael L. Grossbard. (1996) Purine Analogs for the Treatment of Low-Grade Lymphoproliferative Disorders. The Oncologist 1:3, pages 125-139.
Crossref
P. L. Zinzani, M. Bendandi & S. Tura. (2009) FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphoma. European Journal of Haematology 55:4, pages 262-266.
Crossref
P. L. Zinzani, F. Gherlinzoni, M. Bendandi, A. Zaccaria, E. Aitini, M. Salvucci & S. Tura. (2009) Fludarabine treatment in resistant Waldenstrom's macroglobulinemia. European Journal of Haematology 54:2, pages 120-123.
Crossref
P. L. Zinzani, P. Tosi, G. Visani, G. Martinelli, P. Farabegoli, M. Buzzi, E. Ottaviani, M. Salvucci, M. Bendandi, A. Zaccaria & S. Tura. (2006) Apoptosis induction with three nucleoside analogs on freshly isolated B‐chronic lymphocytic leukemia cells. American Journal of Hematology 47:4, pages 301-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.